Table 1. Baseline parameters of post-ACS patients.
| Post-ACS patients (n = 33) | |
|---|---|
| Age (years) | 62±2 |
| Men | 26 (79%) |
| Family history | 16/33 (49%) |
| Actual Percutaneous transluminal coronary angioplasty | 33/33 (100%) |
| Actual Myocardial infarction | 29/33 (88%) |
| Actual Unstable angina | 4/33 (21%) |
| Hypertension | 21/33 (64%) |
| Type II diabetes | 4/33 (12%) |
| Dyslipidemia | 27/33(82%) |
| Obesity | 21/33 (64%) |
| Smoking | 5/33 (15%) |
| Ex smoking | 19/33 (58%) |
| Medication | |
| Statins | 32/33 (97%) |
| Aspirin | 32/33 (97%) |
| β-blockers | 28/33 (85%) |
| Angiotensin Converting Enzyme inhibitors | 26/33 (79%) |
| Clopidogrel/Pasugrel | 24/33 (73%) |
| Nitrates | 14/33 (42%) |
| Calcium channel blockers | 2/33 (6%) |
| Angiotensin II receptor antagonists | 3/33 (9%) |
Data are mean ± SEM of n participants.